Journey Medical NASDAQ DERM Reports 21 Revenue Growth in Q1 2026 Remains Unprofitable Neelkanth Mishra Signals Potential Repo Rate Decline to Decade Low Eyes Market Uptick Kronos Worldwide KRO Slips 766 Testing 641 Support 20260515 UK Exports to the US Plunge by 25 After Trumps Liberation Day Tariffs Blitz